PRCT
PROCEPT BioRobotics Corporation
Medical Devices · Healthcare · United States
19.20
close · 2026-10-30
value
38
cheaper than peers38
quality
54
stronger fundamentals54
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| earnings yield, 1 year ago | -9.1% | 49 |
| earnings yield, 3 years ago | -10.2% | 48 |
| earnings yield, latest year | -9.0% | 47 |
| price to book | 3.23× | 47 |
| earnings yield, 2 years ago | -11.7% | 46 |
| price to sales | 3.24× | 45 |
| cash flow yield, 3 years ago | -7.6% | 44 |
| cash flow yield, latest year | -5.3% | 44 |
| cash flow yield, 1 year ago | -9.5% | 40 |
| cash flow yield, 2 years ago | -12.2% | 37 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 19.3% | 74 |
| debt to equity | 22.8% | 63 |
| return on equity | -30.2% | 40 |
| operating margin | -29.0% | 33 |
4 of 4 measures available
Facts
| market cap | $1B |
| free cash flow | -$57.8M |
| employees | 888 |
| first trade | 2021-09-15 |
| next earnings | 2026-11-04 |
| fundamentals updated | 2026-08-07 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 | 2021 |
| diluted eps | -1.72 | -1.75 | -2.24 | -1.96 | not reported |
| free cash flow | -$58.3M | -$103.6M | -$133.2M | -$83.0M | not reported |
| net income | -$95.6M | -$91.4M | -$105.9M | -$87.2M | not reported |
| revenue | $308.1M | $224.5M | $136.2M | $75.0M | not reported |
| unusual items | not reported | -$114,000 | -$107,000 | -$3.5M | $199,000 |